Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

• Kaibo Ding,
• Zhongsheng Peng,
• Dujiang Liu,
• Yanjun Xu

Affiliations

Kaibo Ding

Department of Medical Thoracic Oncology, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences

Zhongsheng Peng

Department of Medical Thoracic Oncology, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences

Dujiang Liu

Department of Medical Thoracic Oncology, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences

Yanjun Xu

Department of Medical Thoracic Oncology, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences